Fujifilm Diosynth Biotechnologies announced that it will expand its pharmaceutical manufacturing facility in Holly Springs, North Carolina, by investing $1.2 billion to add 425,500 square feet and establish one of the largest end-to-end cell culture biopharmaceutical CDMO facilities in North America and create an additional 680 jobs.
Japanese Firm To Invest $1.2 Billion To Expand Biopharma Manufacturing Facility Near Raleigh
Fujifilm Diosynth Building One of the Biggest Biomanufacturing Facilities of Its Kind in North America, Expansion Expected To Add 680 New Jobs
CoStar Analytics
April 11, 2024 | 9:34 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Fujifilm Diosynth Biotechnologies
Holly Springs New Hill Rd, Holly Springs, NC